Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000612895 | SCV000730579 | likely benign | not specified | 2017-11-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Mendelics | RCV000988858 | SCV001138750 | benign | Hepatitis C virus, susceptibility to | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV001258260 | SCV001435175 | likely benign | Inflammatory bowel disease | criteria provided, single submitter | research | The heterozygous p.Ile63Val variant, sometimes called p.Ile91Val due to a difference in cDNA numbering, in KRT8 has been identified in an individual with inflammatory bowel disease (PMID: 15090596), but has also been identified in >1% of South Asian chromosomes and 4 homozygotes by ExAC (http://gnomad.broadinstitute.org/). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely benign for inflammatory bowel disease. | |
Breakthrough Genomics, |
RCV000056939 | SCV005213198 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Epithelial Biology; Institute of Medical Biology, |
RCV000056939 | SCV000088052 | not provided | not provided | no assertion provided | not provided |